Immune Response BioPharma, Inc.
5 clinical trials · Sponsor
◉ Watch Immune Response BioPharma, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis (NCT02200718) | Immune Response BioPharma, Inc. | 2020-12-31 |
| A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis (NCT02057159) | Immune Response BioPharma, Inc. | 2020-03-09 |
| A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis (NCT02149706) | Immune Response BioPharma, Inc. | 2020-03-09 |
| REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study (NCT02291809) | Immune Response BioPharma, Inc. | 2017-11-01 |
| REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study (NCT02366026) | Immune Response BioPharma, Inc. | 2017-06-01 |
Track Immune Response BioPharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.